Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)(aEuro)

DSpace Repository

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)(aEuro)

Author: Joerger, M.; von Pawel, J.; Kraff, S.; Fischer, J. R.; Eberhardt, W.; Gauler, T. C.; Mueller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Mayer, F.; Kopp, H. -G.; Behringer, D. M.; Ko, Y. -D.; Hilger, R. A.; Roessler, M.; Kloft, C.; Henrich, A.; Moritz, B.; Miller, M. C.; Salamone, S. J.; Jaehde, U.
Tübinger Autor(en):
Mayer, Frank
Kopp, Hans-Georg
Published in: Annals of Oncology (2016), Bd. 27, H. 10, S. 1895-1902
Verlagsangabe: Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/annonc/mdw290
ISSN: 1569-8041
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)